InsidersTradesSigma
翔宇医疗 Stock: price and management transactions · China · SSE / SZSE (CSRC)
Follow the 翔宇医疗 share price and the full insider trade history of the company, a publicly traded company based in China. Shares trade on CN CN, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 翔宇医疗 has published 8 reports. Market capitalisation: €9.7bn. The latest transaction was filed on 1 June 2022 (Purchase). Among the most active insiders: 何永正. The full history is accessible without an account.
8
Insider Decl.
0
Thresholds
·
8 ops.
Buy Volume
·
0 ops.
Sell Volume
10Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 15,695 of 25,564 companies
44.9
score / 100
Value36
Quality54
FCF yld-1.3%
Earn yld1.0%
EV/EBITDA·
ROE3.8%
Gross mgn67%
Net mgn10%
Debt/EBITDA4.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 1 June 2022
Declarations8 total
8 of 8 declarations